tirzepatide weight loss nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and Obesity (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy The results are finally in

Our electrophysiological analyses revealed that exendin 939 likely binds to the extracellular side of TRPV1, offering selective and potent antagonism for pain relief

Amanda Andrade-Rhoades/The Associated Press Anna Wysocks aha moment arrived in an Ohio amusement park, as she got ready to ride a roller coaster with her 7-year-old son: The safety bar across her lap would only click into place once

Compounders were supposed to cease manufacturing their versions in the months after, but many have continued, buoyed by the consumer-driven market and the vast network of options that essentially have the agency playing whack-a-mole.

Baekdal TA, Thomsen M, Kupov V, Hansen CW, Anderson TW

Contraindications : It should not be used in patients with a history of medullary thyroid carcinoma, MEN2, severe gastroparesis, pregnancy, or uncontrolled GI disease

Smaller, more frequent meals tend to feel better and support steadier nutrient intake throughout the day